Idiopathic interstitial pneumonias: Usual interstitial pneumonia versus nonspecific interstitial pneumonia

Proceedings of the American Thoracic Society

Volumn 3, Issue 1, 2006, Pages 81-95

  Martinez, Fernando J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Idiopathic interstitial pneumonia; Idiopathic pulmonary fibrosis; Nonspecific interstitial pneumonia; Usual interstitial pneumonia

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ETANERCEPT; FG 3019; GAMMA1B INTERFERON; IMATINIB; IMMUNOSUPPRESSIVE AGENT; PIRFENIDONE; PREDNISONE; RAPAMYCIN; STEROID; TETRATHIOMOLYBDIC ACID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; ZILEUTON;

BONE MARROW TOXICITY; BRONCHOSCOPY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HISTOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG FUNCTION; LUNG LAVAGE; LUNG VOLUME; PHYSICAL EXAMINATION; PROGNOSIS; RADIODIAGNOSIS; RADIOGRAPHY; REVIEW; SMOKING; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES, INTERSTITIAL; PROGNOSIS;

EID: 33644556832     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200511-123JH     Document Type: Review

References (127)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, Jain A, Strawderman RL III, Paine R III, Flint A, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002;19:275-283.
3. Flaherty KR, King TE Jr, Raghu G, Lynch JP III, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Qi L, et al. Idiopathic interstitial pneumonia: what is the effect of a multi-disciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170:904-910.
4. Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR, Hasleton PS, Kerr KM, Ibrahim NBN, Stewart S, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004;59:500-505.
5. Aziz ZA, Wells AU, Hansell DM, Bain GA, Copley SJ, Desai SR, Ellis SM, Gleeson FV, Grubnic S, Nicholson AG, et al. HRCT diagnosis of diffuse parenchymal lung disease: interobserver variation. Thorax 2004;59:506-511.
6. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Vassilakis DA, Black CM, du Bois RM. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-1586.
7. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadrane J, Delaval P, Ternamian PJ, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22:245-250.
8. Yamadori I, Fujita J, Bandoh S, Tokuda M, Tanimoto Y, Kataoka M, Yamasaki Y, Yoshinouchi T, Ohtsuki Y, Ishida T. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren's syndrome. Rheumatol Int 2002;22:89-92.
9. Douglas WW, Tazelaar HD, Hartman TE, Decker PA, Schroeder DR, Ryu JH. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-1185.
10. Fujita J, Yoshinouchi T, Ohtsuki Y, Tokuda M, Yang Y, Yamadori I, Bandoh S, Ishida T, Takahara J, Ueda N. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001;60:281-283.
11. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:121-127.
12. Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-596.
13. Nakamura Y, Chida K, Suda T, Hayakawa H, Iwata M, Imokawa S, Tsuchiya T, Ida M, Gemma H, Yasuda K, et al. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:235-241.
14. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch JP III, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167:1410-1415.
15. Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T. Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia." Respir Med 2005;99:234-240.
16. British Thoracic Society. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999;54:S1-S30.
17. King TE. Interstitial lung disease, 3rd ed. Hamilton, London: B.C. Decker; 1998.
18. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000;152:307-315.
19. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001;108:661-670.
20. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, et al. HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
21. Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE Jr, Brown KK. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002;112:490-493.
22. Perez-Padilla R, Salas J, Chapela R. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis 1993;148:49-53.
23. Hayakawa H, Shirai M, Sato A, Yoshizawa Y, Todate A, Imokawa S, Suda T, Chida K, Tamura R, Ishihara K, et al. Clinicopathological features of chronic hypersensitivity pneumonitis. Respirology 2002;7:359-364.
24. Selman M. Hypersensitivity pneumonitis: amultifaceted deceiving disorder. Clin Chest Med 2004;25:531-547.
25. Ohtani Y, Saiki S, Kitaichi M, Usui N, Costabel U, Yoshizawa Y. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60:665-671.
26. Hartman TE. The HRCT features of extrinsic allergic alveolitis. Semin Respir Crit Care Med 2003;24:419-425.
27. Flink JN, Ortega HG, Reynolds HY, Cormier YF, Fan LL, Franks TJ, Kreiss K, Kunkel SL, Lynch D, Quirce S, et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 2005;171:792-798.
28. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, Aziz N, Kaminski N, Zlotnick A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198.
29. Lantuejoul S, Brambilla E, Brambilla C, Devouassoux G. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J 2002;19:577-580.
30. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005;172:268-279.
31. Flaherty KR, Martinez FJ. Cigarette smoking in interstitial lung disease: concepts for the internist. Med Clin North Am 2004;88:1643-1653.
32. Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001;17:122-132.
33. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, Burch LH, Wahidi MM, Phillips JA III, Sporn TA, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005;172:1146-1152.
34. King TE Jr, Tooze JA, Schwarz MI, Brown K, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.
35. Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur Respir J 2005;25:915-927.
36. Garcia CK, Raghu G. Inherited interstitial lung disease. Clin Chest Med 2004;25:421-433.
37. Chibbar R, Shih F, Baga M, Torlakovic E, Ramlall K, Skomro R, Cockcroft DW, Lemire EG. Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol 2004;17:973-980.
38. Thomas AQ, Lane K, Phillips J III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-1328.
39. Zorzetto M, Ferrarotti I, Trisolini R, Agli LL, Scabini R, Novo M, De Silvestri A, Patelli M, Martinetti M, Cuccia MC, et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:330-334.
40. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, et al. Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:431-435.
41. O'Donnell DE. Physiology of interstitial lung disease. In: Schwarz M, King T Jr, editors. Interstitial lung disease. Hamilton, ON, Canada: B.C. Decker; 1998. pp. 51-70.
42. Cherniak RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA Jr, Ackerson L, Schwarz MI, King TE Jr. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995;151:1180-1188.
43. Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997;52:998-1002.
44. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-593.
45. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP III, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-1090.
46. Egan JJ, Martinez FJ, Wells AU, Williams T. Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification. Thorax 2005;60:270-273.
47. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001;164:103-108.
48. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, et al., for the Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488-493.
49. Jegal U, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:639-644.
50. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-537.
51. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis WD, Flint A, Toews GB, Lynch JP, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:543-548.
52. Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538-542.
53. King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. Analyses of efficacy end points in a controlled trial of interferon-g1b for idopathic pulmonary fibrosis. Chest 2005;127:171-177.
54. Wells AU, Desai SR, Rubens MB, Goh NSL, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003;167:962-969.
55. Miki K, Maekura R, Hiraga T, Okuda Y, Okamato T, Hirotani A, Ogura T. Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 2003;97:482-490.
56. Timmer SJ, Karamzadeh AM, Yung GL, Kriett J, Jamieson SW, Smith CM. Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival? Chest 2002;122:779-784.
57. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25:96-103.
58. Eaton T, Young PR, Mimlne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:1150-1157.
59. Orens JB, Kazerooni EA, Martinez FJ, Curtis JL, Gross BH, Flint A, Lynch JP III. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy: a prospective study. Chest 1995;108:109-115.
60. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978;298:934-939.
61. Fischer T, Reynolds JH, Trotter SE. The idiopathic interstitial pneumonias: a beginner's guide. Imaging 2004;16:37-49.
62. Lynch DA, Travis WA, Muller NL, Galvin JR, Hansell DM, Grenier PA, King TE Jr. Idiopathic interstitial pneumonias: CT features. Radiology 2005;236:10-21.
63. Wells A. Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis. Thorax 1998;53:1080-1087.
64. Hansell DM. High-resolution computed tomography in the evaluation of fibrosing alveolitis. Clin Chest Med 1999;20:739-760.
65. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-196.
66. Hunninghake GW, Lynch DA, Galvin JR, Muller N, Schwartz D, King TE Jr, Lynch JP III, Hegele R, Waldron JA Jr, Colby TV, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124:1215-1223.
67. Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999;116:1168-1174.
68. Elliott TL, Lynch DA, Newell JD Jr, Cool C, Tuder R, Markopoulou K, Veve R, Brown KB. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr 2005;29:339-345.
69. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000;161:646-664.
70. Hartman TE, Swensen SJ, Hansell DM, Colby TV, Myers JL, Tazelaar HD, Nicholson AG, Wells AU, Ryu Jay H, Mu'adhdin DE, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000;217:701-705.
71. MacDonald SLS, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, Nicholson AG, Colby TV, Wells AU. Nonspecific interstitial pneumonia and usual interstitial pnuemonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600-605.
72. Nagai S, Handa T, Tabuena R, Kitaichi M, Izumi T. Nonspecific interstitial pneumonia: a real clinical entity? Clin Chest Med 2004;25:705-715.
73. Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M, Ichikado K, Ando M, Nakamura H. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999;211:555-560.
74. Koyama M, Johkoh T, Honda O, Tsubamoto M, Kozuba T, Tomiyama N, Hamada S, Nakamura H, Akira M, Ichikado K, et al. Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol 2003;180:827-835.
75. Flaherty K, Wells A, Du Bois R, Nicholson AG, Brown K, Lynch D, Wadenstorer F, Vyskocil J, Bassily N, Louvar E, et al. Diagnostic agreement between academic and community radiologists for cases of idiopathic interstitial pneumonia [abstract]. Proc Am Thorac Soc 2005;2:A122.
76. Drent M, von Nierop MAMF, Gerritsen FA, Wouters EF, Mulder PG. A computer program using BALF analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996;153:736-741.
77. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-1006.
78. Veeraraghavan S, Latsi PI, Wells AU, Pantelidis P, Nicholson AG, Colby TV, Haslam PL, Renzoni EA, du Bois RM. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003;22:239-244.
79. Schwarz MI. 1998. Approach to the understanding, diagnosis, and management of interstitial lung disease. In: Schwarz M, King T Jr, editors. Interstitial lung disease. Hamilton, ON, Canada: B.C. Decker; 1998. pp. 3-30.
80. Watanabe K, Higuchi K, Ninomiya K, Ohshima T,Aritomi T,Kawabata Y, Yoshida A. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 2002;20:1213-1219.
81. Chang AC, Yee J, Orringer MB, Iannettoni MD. Diagnostic thoracoscopic lung biopsy: an outpatient experience. Ann Thorac Surg 2002;74:1942-1946.
82. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
83. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Am J Surg Pathol 2000;24:19-33.
84. Nicholson AG, Colby TV, DuBois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-2217.
85. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL III, Flint A, Lynch JP III, et al. Histologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001;164:1722-1727.
86. Flaherty KR, Wells AU, du Bois RM, Nicholson A, Lynch D, Wadenstorer F, Vyskocil J, Bassily N, Louvar E, Wilt J, et al. Diagnostic agreement between academic and community pathologists for cases of idiopathic interstitial pneumonia [abstract]. Proc Am Thorac Soc 2005;2:A387.
87. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002;26:1567-1577.
88. Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004;125:522-526.
89. Thannickal VJ, Flaherty KR, Hyzy RC, Lynch JP III. Emerging drugs for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs 2005;10:707-727.
90. Bouros D, Antonious KM. Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 2005;26:693-702.
91. Martinez FJ, Thannickal VJ, Travis WD, Hogaboam CM, Flaherty KR, Lynch JP III. Nonspecific interstitial pneumonia (NSIP): a review of clinical and biological processes. Treat Respir Med (In press).
92. Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395-417.
93. Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151.
94. Park CS, Jeon JW, Park SW, Lim G, Jeong SH, Uh ST, Park JS, Choi DI, Jin SY, Kang CH. Nonspecific interstitial pneumonia/fibrosis: clinical manifestations, histologic and radiologic features. Korean J Intern Med 1996;11:122-132.
95. Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000;55:854-859.
96. Flaherty KR, Toews GB, Lynch JP III, Kazerooni EA, Gross BH, Strawderman RL, Hariharan K, Flint A, Martinez FJ. Steroids in idiopathic pulmonary fibrosis: prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001;110:278-282.
97. Richeldi L, Davies HR, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003;3:CD002880.
98. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Pardee NE, Winterbauer RH. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991;144:291-296.
99. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE Jr, Brown KK. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest 2004;125:2169-2174.
100. Raghu G, Brown KK, Bradford WZ, Starko KM, Noble PW, Schwartz DA, King TE Jr, for the Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;30:125-133.
101. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, et al., for the Idiopathic Pulmonary Fibrosis Study Group. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-967.
102. Azuma A, Nukiwa T, Tsubol E, Suga M, Abe S, Nakata K, Taguchi Y, Nagal S, Itoh H, Ohl M, et al., for the members of the Research Group for the Diffuse Lung Diseases in Japan. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-1047.
103. Raghu G, Lasky JA, Costabel U, Brown KK, Cottin V, Thomeer M, Utz J,McDermott L.A randomized placebo controlled trial assessing the efficacy and safety of etanercept in patients with idiopathic pulmonary fibrosis (IPF). Chest 2005;128:496S.
104. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Mohacsi PJ, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report-2003. J Heart Lung Transplant 2003;22:625-635.
105. Ouwens JP, Groen H, TenVergert EM, Koeter GH, de Boer WJ, van der BijW; National Steering Group for Lung Transplantation. Simulated waiting list prioritization for equitable allocation of donor lungs. J Heart Lung Transplant 2002;21:797-803.
106. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226-232.
107. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease: the Eurotransplant experience. J Heart Lung Transplant 2001;20:518-524.
108. Thabut G, MalH, Castier Y, Groussard O, Brugiere O, Marrash-Chahla R, Leseche G, Fournier M. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003;126:469-475.
109. Nathan SD. Lung transplantation: disease-specific considerations for referral. Chest 2005;127:1006-1016.
110. Martinez FJ, Flaherty KR. Diagnosis of interstitial lung disease. Pulmonary and critical care update (PCCU). American College of Chest Physicians. Available from: http://www.chestnet.org/education/online/ pccu/vol18/ lessons03_04/lesson3.php (accessed November 21, 2005).
111. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143-148.
112. Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994;18:136-147.
113. Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-1293.
114. Fujita J, Yamadori I, Suemitsu I, Yoshinouchi T, Ohtsuki Y, Yamaji Y, Kamei T,Kobayashi M, Nakamura Y, Takahara J. Clinical features of non-specific interstitial pneumonia. Respir Med 1999;93:113-118.
115. Park CS, Jeon JW, Park SW, Lim GI, Jeong SH, Uh ST, Park JS, Choi DL, Jin SY, Kang CH. Nonspecific interstitial pneumonia/fibrosis: clinical manifestations, histologic and radiologic features. Korean J Intern Med 1996;11:122-132.
116. Nagai S, Kitaichi M, Itoh H, Nishimura K, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010-1019.
117. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schoreder DR, Offord KP. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203.
118. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, duBois RM. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
119. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific intersititial pneumonia: prognostic significance of cellular and fibrosing patterns. Am J Surg Pathol 2000;24:19-33.
120. Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 2002;19:1114-1118.
121. Shimizu S, Yoshinouchi T, Ohtsuki Y, Fujita J, Sugiura Y, Banno S, Yamadori I, Eimoto T, Ueda R. The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia. Respir Med 2002;96:770-776.
122. Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, Matsukura S, Kohno S. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003;58:52-57.
123. Mageto Y, Flaherty K, Brown K, Fong A, Raghu G. Safety and tolerability of human monoclonal antibody FG-2019, anti-connective tissue growth factor, in patients with idiopathic pulmonary fibrosis. Chest 2004;126:773S.
124. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al., for the IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-2242.
125. Hunninghake GW. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2285-2287.
126. Kubo H, Nakayam K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005;128:1475-1482.
127. Martinez FJ, Bradford WZ, Safrin S, Starko KM, Brown KK. Rates and characteristics of death in patients with idiopathic pulmonary fibrosis (IPF). Chest 2003;124:117S.